Zynex submits fda application for its next generation fluid and blood volume monitor

Englewood, colo., jan. 3, 2022 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has submitted a 510(k) application to the u.s. food and drug administration ("fda") for the cm-1600, its next generation fluid monitoring system.
ZYXI Ratings Summary
ZYXI Quant Ranking